Clinical Predictors of Dosimetric Precedence for Deep Inspiratory Breath Hold Radiation Therapy for Breast Cancer
Diagnostics · 21.04.2026 · 16 (8) · 1236
DOI: 10.3390/diagnostics16081236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 21.04.2026. Verfasst von Alzahra'a Al Matairi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, The University of Jordan, Amman 11942, Jordan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Radiation therapy for left-sided breast cancer exposes the heart and lungs to incidental radiation, increasing long-term risk of cardiopulmonary morbidity. This study evaluated the dosimetric impact of DIBH compared with free breathing (FB) and explored patient- and treatment-related predictors of benefit.
Methods
We retrospectively analyzed 90 patients with left-sided breast cancer or chest wall irradiation planned under both FB and DIBH. Dosimetric parameters included mean heart dose (MHD), mean lung dose (MLD), heart V5, and lung V20. Univariable analyses assessed associations between dose reductions (Δ%) and clinical factors (age, BMI, fractionation, boost, nodal fields, and smoking). Multivariable regression identified independent predictors.
Results
DIBH significantly reduced mean doses to the heart (FB 4.25 ± 1.47 Gy vs. DIBH 2.64 ± 1.28 Gy; Δ −1.60 Gy, p < 0.001, and Cohen’s d = 2.46) and lung (FB 14.00 ± 3.45 Gy vs. DIBH 11.64 ± 3.32 Gy; Δ −2.36 Gy, p < 0.001, and Cohen’s d = 2.73). Similarly, heart V5 (median Δ −10.5%, p < 0.001) and lung V20 (median Δ −5.5%, p < 0.001) were significantly improved. Higher BMI was independently associated with smaller relative reductions in MHD (−1.4% per unit, p < 0.001) and MLD (−0.31% per unit, p = 0.019). Hypofractionation was linked to greater MHD and MLD reductions (+8.9%, p = 0.007), (3.7%, p = 0.035), respectively. Supraclavicular field irradiation increased lung exposure, while internal mammary chain fields elevated both lung and heart doses. Age showed no significant influence.
Conclusions
DIBH provides robust and consistent reductions in cardiac and pulmonary radiation doses during left-sided breast irradiation. The degree of sparing is modulated by BMI, fractionation, and nodal field inclusion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, The University of Jordan, Amman 11942, Jordan.
- Department of Radiation Oncology, King Hussein Cancer Center, Amman 11941, Jordan.
- Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Suez University, Suez 43518, Egypt.
- Department of Medical Oncology, King Hussein Cancer Center, Amman 11941, Jordan.
ORCID-Profile: Abdulla Alzibdeh, Issa Mohamad, Ramiz Abu-Hijlih, Hikmat Abdel-Razeq, Fawzi Abuhijla
Zitieren
APA
Al Matairi, A., Alzibdeh, A., Mohamad, I., Abu-Hijlih, R., Asha, W., Abdel Rahman, F., Kanaan, H., Ahmad, S., Abdel-Razeq, H., & Abuhijla, F. (2026). Clinical Predictors of Dosimetric Precedence for Deep Inspiratory Breath Hold Radiation Therapy for Breast Cancer. Diagnostics, 16(8), 1236. https://doi.org/10.3390/diagnostics16081236
Vancouver
Al Matairi A, Alzibdeh A, Mohamad I, Abu-Hijlih R, Asha W, Abdel Rahman F, et al. Clinical Predictors of Dosimetric Precedence for Deep Inspiratory Breath Hold Radiation Therapy for Breast Cancer. Diagnostics. 2026;16(8):1236. doi:10.3390/diagnostics16081236
BibTeX
@article{AlMatairi2026,
author = {Al Matairi, Alzahra'a and Alzibdeh, Abdulla and Mohamad, Issa and Abu-Hijlih, Ramiz and Asha, Wafa and Abdel Rahman, Fadwa and Kanaan, Haitham and Ahmad, Soha and Abdel-Razeq, Hikmat and Abuhijla, Fawzi},
title = {Clinical Predictors of Dosimetric Precedence for Deep Inspiratory Breath Hold Radiation Therapy for Breast Cancer},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {8},
pages = {1236},
doi = {10.3390/diagnostics16081236}
}
EUVIMED